HK1 and Hepatic fibrosis: Anti-hexokinase 1 (HK1) antibodies revealed a specific association with a higher likelihood of LREs and lower transplant-free survival, while anti-Kelch-like 12 (KLHL12) antibodies showed a link to advanced liver fibrosis and elevated bilirubin levels [174].